Research into the link between Parkinson’s and the gut microbiome in modulating human brain function has grown over the past ten years. However, most of these studies have been done chiefly in animal designs.
Increasing medical and preclinical trials are implicating the microbiome as being a possible key factor for neurological disorders, including alzheimer’s disease, autism, multiple sclerosis, parkinson’s disease, heart disease and stroke.
Individuals with parkinson’s disease have abnormal clumps of unhealthy proteins called lewy bodies. These clumps are largely composed of another unhealthy protein called alpha-synuclein, which plays a role in crosstalk between brain tissue. These proteins disrupt the communication within the brain and are regarded as toxic to certain neurons.
A big revelation for medical professionals have been that gut microorganisms may be able to gradually reverse the introduction of a proteins responsible for parkinson’s. As outlined by a research article cited by the school of edinburgh analysis,
Researchers determined that bacillus subtilis, a probiotic, stalled the develop-up of harmful clumps that build up in the brain and rob a the brain of dopamine.
Dopamine allows communications being transported to and from the regions of the mind coordinating the motion of your body. We are looking forward to more research and information on the benefits of a healthy gut.